Istradefylline
From Self-sufficiency
File:Istradefylline.svg | |
Systematic (IUPAC) name | |
---|---|
8-[(E)-2-(3,4-dimethoxyphenyl)vinyl]-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione | |
Identifiers | |
CAS Number | 155270-99-8 |
ATC code | none |
PubChem | CID 5311037 |
Chemical data | |
Formula | C20H24N4O4 |
Molar mass | 384.429 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Istradefylline (KW-6002) is an antagonist at the A2A receptor. It has been found to be useful in the treatment of Parkinson's disease.[1] Istradefylline reduces dyskinesia resulting from long-term treatment with classical antiparkinson drugs such as levodopa.
This pharmacology-related article is a stub. You can help ssf by expanding it. |
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
- ↑ Peter A. LeWitt, MD, M. Guttman, James W. Tetrud, MD, Paul J. Tuite, MD, Akihisa Mori, PhD, Philip Chaikin, PharmD, MD, Neil M. Sussman, MD (2008). "Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces off time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005)". Annals of Neurology. 63 (3): 295–302. doi:10.1002/ana.21315. PMID 18306243.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Pharmacology stubs
- Xanthines
- Phenol ethers
- Alkenes
- 2Fix
- CS1 maint: Multiple names: authors list